Precision Neuroscience raised a $250 million Series D to advance regulatory approval for permanent brain-computer implants.
- Amount
- $250M
- Stage
- Series D
- Announced
- 24 September 2026
- Leads
- Pershing Square Inc., Ackman Oxman Institute, an undisclosed leading life sciences investment fund
- Other investors
- Duquesne Family Office, B Capital, ARK Invest, Invus, Mubadala Capital, Mirae Asset Capital, Korea Investment Partners, Hitachi Ventures, JSL Health Capital
- Total raised
- $430M to date
- Checked
- Amount and date matched across 2 press sources